Patent: 10,004,803
✉ Email this page to a colleague
Summary for Patent: 10,004,803
| Title: | Low, immune enhancing, dose mtor inhibitors and uses thereof |
| Abstract: | The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, for example, with low, immune enhancing, doses of an mTOR inhibitor, such as RAD001. |
| Inventor(s): | Mannick Joan, Glass David, Murphy Leon |
| Assignee: | Novartis AG |
| Application Number: | US15292088 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,004,803
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Biologicals | FLUARIX, FLUARIX QUADRIVALENT | influenza vaccine | Injection | 125127 | August 31, 2005 | ⤷ Start Trial | 2036-10-12 |
| Glaxosmithkline Biologicals | FLUARIX, FLUARIX QUADRIVALENT | influenza vaccine | Injection | 125127 | December 14, 2012 | ⤷ Start Trial | 2036-10-12 |
| Id Biomedical Corporation Of Quebec | FLULAVAL, FLULAVAL QUADRIVALENT | influenza vaccine | Injection | 125163 | October 05, 2006 | ⤷ Start Trial | 2036-10-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
